Vaginal News and Research

RSS

Vaginal health

Silence may impact women's health since few women or their doctors are comfortable talking about vaginal health openly.

11 Jul 2007

U.S. trial of new microbicide for HIV prevention to be tested in young women

Nearly half of all people infected with HIV/AIDS are now women, the majority of whom contracted the disease through sexual intercourse with male partners.

10 Jul 2007

Syphilis cases spike in New York City

After leveling off for more than two years, and declining in 2006, new syphilis cases spiked in New York City during the first three months of 2007.

10 Jul 2007

Bio-adhesive vaginal foam

Foamix Ltd. has announced that the Company has been selected to present at the 34th Annual Meeting of the Controlled Release Society.

10 Jul 2007

U.S. NIH funded trial of VivaGel in sexually active young women commences

Starpharma Holdings Limited today announced the commencement in the U.S. of a trial to assess the safety and acceptability of SPL7013 Gel (VivaGel) in sexually active young women.

9 Jul 2007

Injections of autologous myoblasts and fibroblasts could relieve stress urinary incontinence in women

Myoblasts are a type of muscle stem cell, while fibroblasts are cells which form the structural framework for many tissues in the body. Autologous cells are ones which the patient is the source of.

29 Jun 2007

Stanford researchers get scoop on baby poop!

Researchers at the Stanford University School of Medicine are as interested in a baby's poop as doting parents are, and for good reason.

26 Jun 2007

Requiring HPV vaccination for school-age girls for upcoming school year 'too soon,' researcher says

It is premature to require middle-school age girls to receive Merck's human papillomavirus vaccine Gardasil for the upcoming school year, Doug Lowy -- head of the National Cancer Institute's Laboratory of Cellular Oncology and one of the scientists responsible for the development of the vaccine -- said on Wednesday, CQ HealthBeat reports (Bartolf, CQ HealthBeat, 6/20).

22 Jun 2007

New screening kit for vaginal infections

The Vagisil Screening Kit For Vaginal Infections - an inhome screening kit offering rapid results - is now available to help women make a more accurate assessment of what type of infection their vaginal discharge and vulvar symptoms might indicate.

20 Jun 2007

True cost of having a baby

For women insured through large employer private plans, the average cost of having a baby in the United States in 2004 was more than $8,000, according to a study released by the March of Dimes Foundation.

14 Jun 2007

Reducing caesarean rates

A computerised decision analysis programme which helps women decide on the type of birth that is most appropriate for them could cut the number of caesarean sections performed in England and Wales by 4,000 a year, according to a study by researchers at Bristol University published on bmj.com.

3 Jun 2007

International studies show high efficacy for Gardasil

A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer, strains 16 and 18.

1 Jun 2007

FDA approves treatment for bacterial vaginosis

Mission Pharmacal has announced that the U.S. Food and Drug Administration (FDA) approved Tindamax (tinidazole) for the treatment of bacterial vaginosis (BV), the most common vaginal infection among women of childbearing age in the United States.

28 May 2007

Minimally invasive device for treating recurrent stress urinary incontinence in women, safe and effective

A minimally invasive device for treating recurrent stress urinary incontinence in women has been shown to be safe and effective in early clinical trials and is now under review by the U.S. Food and Drug Administration (FDA), says Emory University School of Medicine urologist and trial co-principal investigator Niall Galloway, MD.

24 May 2007

Dramatic increase in Caesarean sections

The report, published in the prestigious international journal, the British Journal of Obstetrics and Gynaecology, found that the rise could not be explained by increases in clinical reasons for caesareans such as complications in pregnancy or labour/delivery and was more likely due to societal factors.

17 May 2007

Merits and risks of postmenopausal hormone therapy

The study was categorized as a primary prevention trial for coronary heart disease, although the fact that mean age at recruitment was 63 years was not given enough importance at that time. WHI investigators concluded that hormone therapy (HT) was not cardioprotective, and, in fact, its riskbenefit ratio did not favor the use of postmenopausal hormones for prevention of chronic diseases.

17 May 2007